What is Genequest Diagnostics?
Genequest Diagnostics operates at the intersection of advanced biotechnology and legal jurisprudence, providing critical forensic genomics services. The company specializes in complex DNA analysis, including nuclear short tandem repeats (STR), mitochondrial DNA (mtDNA), and single nucleotide polymorphism (SNP) profiling. By utilizing state-of-the-art NextGen sequencing technologies, Genequest provides essential support for both criminal and civil litigation. Their market position is defined by a commitment to high-fidelity data, offering comprehensive casefile reviews and expert laboratory re-analysis that serves legal professionals across North America and Europe. As a leader in forensic science, the firm bridges the gap between laboratory precision and courtroom testimony, ensuring that complex genetic data is translated into actionable evidence.
How much funding has Genequest Diagnostics raised?
Genequest Diagnostics has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
Key Investors in Genequest Diagnostics
PPP
Public-Private Partnership
What's next for Genequest Diagnostics?
With the recent influx of capital, Genequest Diagnostics is poised to accelerate its strategic growth initiatives. The firm is expected to focus on expanding its laboratory capacity to meet the rising demand for high-throughput sequencing in legal proceedings. Furthermore, the investment will likely support the development of proprietary analytical software, enhancing the speed and accuracy of their forensic reporting. As the company transitions through its current growth phase, it remains focused on maintaining its reputation for scientific rigor while scaling its operational footprint to capture a larger share of the international forensic services market. Future efforts will likely prioritize the integration of advanced bioinformatics to further refine their diagnostic capabilities in complex, multi-source DNA cases.
See full Genequest Diagnostics company page
